HLA-C and melanoma: In that regard, it has been reported that the targeting of CD4 T cells with DCs pulsed with both MHC class II and MHC class I restricted epitopes of the TAA MAGE-A3 enhances the efficacy of the response in vaccinated melanoma patients, although the frequency of antigen-specific CD4 T cell in the patients remained low [102].